Menu
Enrolling by invitation NCT02664337

Conjoint Analysis of Patient Preferences in Joint Interventions

No phase Interventional Arthritis Femoroacetabular Impingement Osteochondritis Dissecans Hip Fractures

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Decision tool, Standard treatment information.
Who it may be relevant to
Registry conditions: Arthritis, Femoroacetabular Impingement, Osteochondritis Dissecans, Hip Fractures. Basic parameters: 18 years — 85 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

This study is an observational study to test and validate a questionnaire and statistical model used to determine patient preferences regarding treatment for any one of 11 musculoskeletal conditions: hip arthritis, knee arthritis, hip labral tears and femoroacetabular impingement (FAI), osteochondritis dissecans, Achilles tendon rupture, patellofemoral dislocation, distal radius fracture, and fractures of the hip, ankle, tibia, and proximal humerus. This study aims to understand how multiple treatment variables, including pain, rehabilitation time, cost, and choice of surgical versus non-surgical intervention, impact patients' decision-making processes and ultimate choice of treatment.

Interventions

  • Other Decision tool
    A survey will be created for each condition that reflects the most important aspects of the corresponding treatment process.
  • Other Standard treatment information
    Participants will receive information pertaining to one of the 12 specified musculoskeletal conditions. This information will reflect information commonly distributed to patients seeking to make a decision concerning treatment for their condition.

Primary outcome measures

  • Patient preferences survey - Hip Arthritis [Time frame: 3-5 years]
  • Patient preferences survey - Knee Arthritis [Time frame: 2 years]
  • Patient preferences survey - hip labral tears and FAI [Time frame: 3-5 years]
  • Patient preferences survey - Osteochondritis dissecans [Time frame: 3-5 years]
  • Patient preferences survey - Achilles tendon rupture [Time frame: 2 years]
  • Patient preferences survey - patellofemoral dislocation [Time frame: 2 years]
  • Patient preferences survey - distal radius fracture [Time frame: 3-5 years]
  • Patient preferences survey - hip fracture [Time frame: 3-5 years]
  • Patient preferences survey - ankle fracture [Time frame: 3-5 years]
  • Patient preferences survey - tibia fracture [Time frame: 3-5 years]

Eligibility criteria

Inclusion criteria

  • Patient age criteria for each condition is listed below:
  • Hip arthritis: 50-80 years
  • Knee arthritis: 50-80 years
  • Hip labral tears and FAI: 18-65
  • Osteochondritis dissecans: parents with children between the ages of 8-18
  • Achilles tendon rupture: 25-60 years
  • Patellofemoral dislocation: parents with children between the ages of 8-18 and adults between 18-50 years of age
  • Distal radius fracture: 18-80 years
  • Hip fracture: 50-85 years
  • Ankle fracture: 18-80 years
  • Tibia fracture: 18-80 years
  • Proximal humerus fracture: 18-80 years
  • Ankle Arthritis: 40-80 years

Exclusion criteria

  • Inability to read, understand and give effective English consent

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Health services research

Study locations

United States · 1 center
  • Duke University Health System — Durham

Identifiers

NCT: NCT02664337 · Pro00067150

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗